Related Experiment Videos
[Hepatitis C virus in plasmapheresis donors]
G J Padrón1, Z Rodríguez, L Rivera
1Centro de Ingeniería Genética y Biotecnología, Ciudad de La Habana, Cuba.
Sangre
|June 1, 1995
Summary
Hepatitis C virus (HCV) infection is common in plasmapheresis donors. This study found a link between HCV antibodies and liver damage, highlighting transmission risks within donation centers.
Area of Science:
- Virology
- Hepatology
- Public Health
Context:
- High prevalence of Hepatitis C Virus (HCV) infection noted in plasmapheresis donors globally and in Cuba.
- Plasmapheresis units represent a potential environment for HCV transmission.
- Understanding the relationship between laboratory markers and infectious status is crucial.
Purpose:
- To investigate the correlation between anti-HCV antibodies and liver injury in plasmapheresis donors.
- To identify potential routes of HCV infection within this specific population.
- To assess factors associated with anti-HCV positivity, including demographics and donation history.
Summary:
- A study involving 61 plasmapheresis donors revealed a 48.3% HCV infection prevalence.
- A direct correlation was established between anti-HCV antibodies and liver damage (alanine aminotransferase levels).
- HCV positivity was significantly associated with the duration of plasma donation, not age, sex, or race.
Impact:
- The findings underscore the risk of nosocomial HCV transmission in plasmapheresis settings.
- Highlights the importance of stringent infection control measures in blood donation centers.
- Emphasizes the need for early detection and management of HCV in high-risk donor populations.